DCB Club 2025 — Day 2

14 of 17 videos summarized

DCB Club 2025 — Day 2 SATURDAY 8th NOVEMBER: Session 6 - Welcome and Opening Remark - Bruno Scheller Session 7 - DCB-PCI: Current Indications 12 min: Small vs. Large Vessel Disease – Antonio Colombo 4 min: Short update on Cage-Free Trial – Yoshi Onuma 12 min: Bifurcations: Emerging Approaches – David Hildick-Smith 12 min: Diffuse Disease – Amin Ariff Nuruddin 12 min: Chronic Total Occlusions (CTO) – Kambis Mashayekhi Session 8 - MEDTRONIC: Unlocking What’s Next in DCBs: latest data that is shaping real-world decisions and broader adoption 10 min: Prevail clinical data with case illustration: SCAAR, Prevail Global, and EBC DCB – Kambis Mashayekhi 10 min: DCB in small vessels including DAPT considerations, PARIS trial update – Ignacio Amat-Santos 10 min: Physiology-guided side branch intervention with CathWorks FFRangio – Luca Testa Session 9 - BOSTON: Drug Coated Ballons in Modern PCI: shaping contemporary best practices 2 min: Opening: Introduction & learning objectives 7 min: Drug Coated balloons in Modern PCI: From Mechanism of Action to Real Life Practice – Tuomas Rissanen 7 min: DCB therapy in practice – Fernando Alfonso 2 min: Take Home Messages Session 10: DCB-PCI: Current Indications II 12 min: NSTEMI and STEMI – Tuomas Rissanen 12 min: High Bleeding Risk – Tuomas Rissanen 12 min: Calcified Lesions – Sandeep Basavarajaiah Session 11: Therapeutic Strategies and Future Perspectives 12 min: Preventive Therapy of Lipid-Rich Vulnerable Plaques – Jung-Min Ahn 12 min: Management of Dissections – Juan F Iglesias 12 min: Drug Selection: Paclitaxel vs. Sirolimus – Bruno Scheller 12 min: Hybrid vs. DCB-Only Strategy – Paul Knaapen 12 min: Bioresorbable Scaffolds (BRS) vs. DCB – Hector Garcia 35 min: Key Messages for a Consensus Paper – ALL